DANIELLE CARRILLO: Open Payments
NPI 1366992802 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,224 in 56 payments from 12 companies in 2025. Trend: 2023 $1,096 · 2024 $1,385 · 2025 $1,224
Food & beverage: $1,224
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $287 |
| Janssen Biotech, Inc. | 10 | $185 |
| ABBVIE INC. | 10 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $116 |
| Phathom Pharmaceuticals, Inc. | 9 | $114 |
| PFIZER INC. | 4 | $87 |
| Gilead Sciences, Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Ipsen Biopharmaceuticals, Inc | 2 | $53 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
Products named: DUPIXENT, TREMFYA, VOQUEZNA, ENTYVIO, SKYRIZI, IQIRVO, XELJANZ, CREON.
Industry payments across AZ — which companies pay providers there.
